TATVAUpdated 1 Sept 2026, 5:24

Tatva Chin Pharm Chem Ltd

TATVAUpdated 1 Sept 2026, 5:24

Market Cap

₹3,805Cr.

Current Price

₹1,627

High / Low

₹1,839/976

Stock P/E

83.9

ROE5.29%

ROCE6.87%

Book Value₹324

Face Value₹10.0

Dividend Yield0.12%

About

Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	92	80	73	113	53	82	66	90	106
Inventory Days	134	98	165	168	299	249	313	228	268
Days Payable	132	70	88	116	82	52	96	60	91
Cash Conversion Cycle	94	109	150	166	269	278	282	258	283
Working Capital Days	16	46	45	73	72	22	154	139	80
ROCE %	—	22%	27%	28%	26%	8%	7%	0%	7%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 5:24

TATVA CHIN PHARM CHEM LTD (TATVA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding